Speak directly to the analyst to clarify any post sales queries you may have.
The cryptococcosis market continues to evolve, shaped by emerging diagnostic methods, therapeutic advancements, and global health policy shifts. For senior decision-makers, understanding these developments is critical to guiding resource allocation and ensuring optimized patient outcomes in a landscape marked by complex challenges and innovation opportunities.
Market Snapshot: Cryptococcosis Market Dynamics
The Cryptococcosis Market grew from USD 6.35 billion in 2024 to USD 6.87 billion in 2025. It is expected to continue growing at a CAGR of 7.68%, reaching USD 9.91 billion by 2030.
Scope & Segmentation of the Cryptococcosis Market
This report offers comprehensive analysis and forecasting across all pivotal aspects of the cryptococcosis market. It highlights advances in diagnostics and therapy while detailing market structure by classes, indications, routes, end users, distribution channels, and regional footprint. Key areas include:
- Drug Class: Azoles (Fluconazole, Isavuconazole, Itraconazole, Posaconazole, Voriconazole), Echinocandins (Anidulafungin, Caspofungin, Micafungin), Polyenes, Pyrimidine Analogues
- Indication: Cryptococcal Meningitis, Disseminated Cryptococcosis, Pulmonary Cryptococcosis
- Route of Administration: Intravenous, Oral
- End User: Ambulatory Care Center, Clinic, Hospital
- Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
- Geographies: Americas (United States—including key states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (comprehensive country scope), Asia-Pacific (China, India, Japan, and other major markets)
- Companies Covered: Gilead Sciences, Viatris, Pfizer, Bausch Health, Merck & Co., Bristol-Myers Squibb, Johnson & Johnson
Key Takeaways for Senior Decision-Makers
- Innovative diagnostics such as rapid antigen assays and molecular platforms are accelerating intervention timelines, with point-of-care adoption expanding especially in regions with robust HIV care frameworks.
- Therapeutic regimens are diversifying, with combination therapies under clinical evaluation and next-generation antifungals aiming to address safety and efficacy gaps in existing protocols.
- Drug class relevance is evident, as azoles anchor induction and consolidation therapy, while newer agents and echinocandins increasingly support maintenance and refractory cases.
- Patient pathways are nuanced by disease complexity, route of administration (oral versus intravenous), and care settings, with rising focus on outpatient and ambulatory management for select segments.
- Distribution strategies balance direct hospital needs, expanding online pharmacy access, and logistics optimization to support treatment continuity in remote and underserved markets.
- Strategic partnerships between biopharmaceutical firms, digital providers, and contract manufacturers are enhancing production agility and driving integrated treatment models.
Tariff Impact on the Antifungal Supply Chain
Impending changes to United States tariff policies in 2025 are set to influence antifungal supply chains, raising costs for active pharmaceutical ingredient imports essential for azole and echinocandin production. Pharmaceutical manufacturers are proactively considering local manufacturing and inventory strategies to protect access and maintain stability in critical medication supply during fiscal transitions.
Methodology & Data Sources
Insights are based on a robust multi-stage methodology incorporating secondary literature reviews, regulatory document analysis, and proprietary data. Thorough input from infectious disease specialists, pharmacologists, and healthcare administrators was triangulated via interviews, while findings were further validated through expert workshops. This framework ensures findings are both comprehensive and reliable.
Why This Report Matters to Executives
- Supports data-driven planning by offering actionable segmentation and pipeline intelligence for portfolio optimization.
- Informs supply chain resilience strategies by analyzing global policy shifts, emerging distribution channels, and potential regulatory disruptions.
- Provides clarity on regional market forces and evolving treatment paradigms, empowering coordinated investment and resource deployment decisions.
Conclusion
This report serves as a strategic tool for navigating the complexities of the cryptococcosis market. Decision-makers will gain evidence-backed perspectives to drive innovation, safeguard equitable access, and address critical clinical and operational needs within the global infectious disease landscape.
Table of Contents
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4.2. Market Sizing & Forecasting
5.2. Adoption of rapid point-of-care diagnostic assays for early cryptococcal antigen detection in resource-limited regions
5.3. Integration of recombinant immune-based treatments to reduce mortality in HIV-associated cryptococcal meningitis
5.4. Development of long-acting injectable formulations to improve adherence in cryptococcosis therapy
5.5. Rising focus on global health initiatives funding screening programs for asymptomatic cryptococcal antigenemia in sub-Saharan Africa
5.6. Clinical trials evaluating combination immunotherapy and antifungal regimens to shorten treatment duration in cryptococcosis
5.7. Implementation of AI-driven predictive modeling for patient outcome optimization in cryptococcal meningitis management
5.8. Emergence of generic fluconazole market dynamics influencing drug pricing and access in developing countries
6.2. PESTLE Analysis
8.2. Azoles
8.2.1. Fluconazole
8.2.2. Isavuconazole
8.2.3. Itraconazole
8.2.4. Posaconazole
8.2.5. Voriconazole
8.3. Echinocandins
8.3.1. Anidulafungin
8.3.2. Caspofungin
8.3.3. Micafungin
8.4. Polyenes
8.5. Pyrimidine Analogues
9.2. Cryptococcal Meningitis
9.3. Disseminated Cryptococcosis
9.4. Pulmonary Cryptococcosis
10.2. Intravenous
10.3. Oral
11.2. Ambulatory Care Center
11.3. Clinic
11.4. Hospital
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Gilead Sciences, Inc.
16.3.2. Viatris Inc.
16.3.3. Pfizer Inc.
16.3.4. Bausch Health Companies Inc.
16.3.5. Merck & Co., Inc.
16.3.6. Bristol-Myers Squibb Company
16.3.7. Johnson & Johnson
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
FIGURE 2. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CRYPTOCOCCOSIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CRYPTOCOCCOSIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CRYPTOCOCCOSIS MARKET: RESEARCHAI
FIGURE 26. CRYPTOCOCCOSIS MARKET: RESEARCHSTATISTICS
FIGURE 27. CRYPTOCOCCOSIS MARKET: RESEARCHCONTACTS
FIGURE 28. CRYPTOCOCCOSIS MARKET: RESEARCHARTICLES
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY FLUCONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ISAVUCONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ISAVUCONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ITRACONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ITRACONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY POSACONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY POSACONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY VORICONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY VORICONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ANIDULAFUNGIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ANIDULAFUNGIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CASPOFUNGIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CASPOFUNGIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY MICAFUNGIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY MICAFUNGIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY POLYENES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY POLYENES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PYRIMIDINE ANALOGUES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PYRIMIDINE ANALOGUES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CRYPTOCOCCAL MENINGITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CRYPTOCOCCAL MENINGITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISSEMINATED CRYPTOCOCCOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISSEMINATED CRYPTOCOCCOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PULMONARY CRYPTOCOCCOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY PULMONARY CRYPTOCOCCOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AMBULATORY CARE CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY AMBULATORY CARE CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CRYPTOCOCCOSIS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CRYPTOCOCCOSIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 102. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 103. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 104. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 105. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 106. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 107. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 108. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 109. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 110. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 111. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. CANADA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 116. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 117. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 118. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 119. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. MEXICO CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 187. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 188. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 189. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 190. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 191. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 192. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 193. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 194. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 195. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. GERMANY CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 202. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 203. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 204. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 205. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 206. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 207. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 208. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 209. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. FRANCE CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 229. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 230. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 231. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 232. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 233. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 234. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 235. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. ITALY CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 244. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 245. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 246. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 247. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 248. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 249. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 250. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 251. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. SPAIN CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 300. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 301. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 302. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 303. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 304. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 305. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 306. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 307. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. DENMARK CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. NETHERLANDS CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 328. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 329. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 330. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 331. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 332. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 333. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 334. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 335. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 336. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 337. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 338. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 339. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 340. QATAR CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 341. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 342. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 343. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 344. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 345. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2018-2024 (USD MILLION)
TABLE 346. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY ECHINOCANDINS, 2025-2030 (USD MILLION)
TABLE 347. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 348. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 349. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 350. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 351. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 354. FINLAND CRYPTOCOCCOSIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 355. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 356. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 357. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 358. SWEDEN CRYPTOCOCCOSIS MARKET SIZE, BY AZOLES, 2
Samples
LOADING...
Companies Mentioned
- Gilead Sciences, Inc.
- Viatris Inc.
- Pfizer Inc.
- Bausch Health Companies Inc.
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Johnson & Johnson
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 194 |
Published | August 2025 |
Forecast Period | 2025 - 2030 |
Estimated Market Value ( USD | $ 6.87 Billion |
Forecasted Market Value ( USD | $ 9.91 Billion |
Compound Annual Growth Rate | 7.6% |
Regions Covered | Global |
No. of Companies Mentioned | 7 |